DuBiotech to showcase technology advancements at Arab Lab - The Expo 2008
- United Arab Emirates: Saturday, February 09 - 2008 at 15:50
- PRESS RELEASE
Dubai Biotechnology and Research Park (DuBiotech), a member of TECOM Investments, will showcase advancements in laboratory and analytical technology in life sciences at Arab Lab - The Expo 2008, one of the largest laboratory and instrumentation industry show in Asia and the Middle East.
Dr. Abdulqader Alkhayat, Executive Director of DuBiotech, said: "We aim to be at the forefront of the life sciences industry by encouraging research and development. Our recent MoU to launch the Gulf Anti-doping and Monitoring Enterprise (GAME), the AED289-million Nucleotide Complex laboratory and the BioTiqania Training Institute will enable Dubai to evolve as the pioneering destination for biotechnology professionals.
"Our support for ArabLab show for the third consecutive year stems from our commitment to nurturing the growing life sciences industry in the region."
ArabLab endeavours to provide an unrivalled forum for the industries to not only showcase their products, but network with professionals and establish greater brand awareness. More than 45 countries are represented in the premier event.
DuBiotech offers the complete value chain to help companies set up their operations. In addition to pharmaceutical and biotechnology companies, it aims to provide the necessary infrastructure for all entities operating in the life sciences industry such as the agricultural, environmental, and marine biotechnology.
At present, 28 companies licensed by DuBiotech are fully operational at the free zone.
Article Options
Notes and Media Contacts »
Announced in February 2005, the Dubai Biotechnology and Research Park (DuBiotech) is a science and business park dedicated to the biotechnology industry, set within a 'free zone'. DuBiotech has two arms. The first is the Foundation for Research and Innovation (FRI) that will initially focus on government-funded R&D in medicine and genetics, plant biotechnology encompassing food and agricultural biotech, environmental biotech and equine-related biotechnology. Other areas include drug discovery, stem cell research, infectious diseases and forensic research. The second arm of DuBiotech aims to set up a biotechnology industry cluster with cutting-edge infrastructure, facilities and services for incubators, R&D labs, biotech-related educational institutions, suppliers, biotech-related manufacturing companies and organizations from other sectors in the industry. DuBiotech is advised by an independent steering committee on scientific, business and ethical matters. In cooperation with global research leader, RTI International, DuBiotech is developing comprehensive regulations that address all aspects of biotech activity. Being in a 'free zone' means biotechnology firms in the park have 100 % exemption from any form of taxation for 50 years, 100 % business ownership and 100 % repatriation of capital.
For further information, please call:
Zeba Ahmad
JiWiN
The Exclusive Middle East Affiliate of Burson-Marsteller
Tel: +9714 361 3590 (direct)
+9714 361 3333 (switchboard)
Fax: +9714 388 8001
Or
Cynthia Luna-Harb
JiWiN
The Exclusive Middle East Affiliate of Burson-Marsteller
Tel: +9714 375 5878 (direct)
+9714 361 3333 (switchboard)
Fax: +9714 388 8001
Disclaimer »
Articles in this section are primarily provided directly by the companies appearing or PR agencies which are solely responsible for the content. The companies concerned may use the above content on their respective web sites provided they link back to http://www.ameinfo.com
Any opinions, advice, statements, offers or other information expressed in this section of the AMEinfo.com Web site are those of the authors and do not necessarily reflect the views of AME Info FZ LLC / Emap Limited. AME Info FZ LLC / Emap Limited is not responsible or liable for the content, accuracy or reliability of any material, advice, opinion or statement in this section of the AMEinfo.com Web site.
For details about submitting your stories, please read the guide - all content published is subject to our terms and conditions

Posted by Medilyn Manibo, Assistant News Editor



